Mephenytoin hydroxylation in the Cuna Amerindians of Panama.
- 1 January 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 25 (1), 75-79
- https://doi.org/10.1111/j.1365-2125.1988.tb03284.x
Abstract
1 Mephenytoin p(4'')-hydroxylation, which is deficient in 3-5% of Caucasians, was examined in 96 Cuna Amerindians of Panama. 2 Attempts were made to exclude poor compliance with urine collection and ingestion of the drug dose since the assignment of phenotype was based upon urinary recovery of the metabolite. These involved the measurement of the urinary recovery of sparteine, added to the ingested capsule, and of the renal excretion of creatinine. 3 Of the 90 Cunas deemed to be reasonably compliant, none of them appeared to be deficient in p(4'')-hydroxylation of mephenytoin.This publication has 10 references indexed in Scilit:
- [Preliminary study of the phenotype for acetylation in Teribe Amerindians].1987
- FAMILY STUDIES OF MEPHENYTOIN HYDROXYLATION DEFICIENCY1986
- No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama [letter]Published by Wiley ,1986
- The genetic defect of mephenytoin hydroxylationXenobiotica, 1986
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Genetic polymorphism of mephenytoin p(4′)‐hydroxylation: difference between Orientals and Caucasians.British Journal of Clinical Pharmacology, 1985
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- Migration and genetic infrastructure of the central american guaymi and their affinities with other tribal groupsAmerican Journal of Physical Anthropology, 1982